Skip to main content
. Author manuscript; available in PMC: 2014 Dec 27.
Published in final edited form as: Nutrition. 2012 Aug 2;29(1):71–75. doi: 10.1016/j.nut.2012.03.016

Table 4.

Relative risk of PWV and TMP-AUC in AGE/CoQ10 versus placebo group

Model Placebo AGE/CoQ10 P
Decrease in PWV* 1.0 (reference) 6.94 (2.1–22.6) 0.001
Decrease in CRP* 1.0 (reference) 7.67 (2.7–21.9) 0.001
Increase in TMP-AUC* 1.0 (reference) 12.60 (3.9–20.6) 0.0001

AGE, aged garlic extract; CoQ10, coenzyme 10; CRP, C-reactive protein; PWV, pulse-wave velocity; TMP-AUC, area under the temperature curve

Values are presented as odds ratio (95% confidence interval). The model was adjusted for age, gender, conventional risk factors, and statin therapy. Logistic regression analysis was used

*

Median annual change: TMP-AUC >9.48 versus ≤9.48, CRP <0 versus ≥0, PWV <0.18 versus ≥0.18.